BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 34 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,009 | -60.1% | 3,057 | -12.9% | 0.00% | – |
| Q4 2022 | $2,527 | -15.8% | 3,510 | +44.9% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 2,422 | -9.3% | 0.00% | – |
| Q1 2022 | $6,000 | -40.0% | 2,671 | -61.7% | 0.00% | – |
| Q4 2021 | $10,000 | +150.0% | 6,974 | +373.8% | 0.00% | – |
| Q3 2021 | $4,000 | -80.0% | 1,472 | -75.1% | 0.00% | – |
| Q2 2021 | $20,000 | -13.0% | 5,909 | -1.6% | 0.00% | – |
| Q1 2021 | $23,000 | -28.1% | 6,007 | -34.8% | 0.00% | – |
| Q4 2020 | $32,000 | -39.6% | 9,209 | +14.7% | 0.00% | – |
| Q3 2020 | $53,000 | -31.2% | 8,028 | -22.6% | 0.00% | – |
| Q2 2020 | $77,000 | +97.4% | 10,369 | +25.3% | 0.00% | – |
| Q1 2020 | $39,000 | – | 8,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $322,633 | 0.08% |
| Long Focus Capital Management, LLC | 327,692 | $235,938 | 0.02% |
| Boxer Capital, LLC | 56,950 | $41,004 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $32,441 | 0.00% |
| Baker Brothers Advisors | 249,123 | $179,369 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $9,318 | 0.00% |
| Parallel Advisors, LLC | 10 | $7 | 0.00% |
| MONEY CONCEPTS CAPITAL CORP | 264 | $190 | 0.00% |
| WELLS FARGO & COMPANY/MN | 781 | $562 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $7,906 | 0.00% |